Latest news
ANI Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 21:22:02 GMTANI Pharmaceuticals Inc (ANIP) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 19:01:35 GMTANI Pharmaceuticals, Inc (ANIP) Q2 2026 Earnings Call Transcript - AlphaStreetAlphaStreet · Fri, 07 Aug 2026 15:19:43 GMTANI Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 14:04:28 GMTANI Pharmaceuticals Shares Slide Despite Earnings Beat After Cortrophin Outlook Cut - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:59:23 GMTANI Pharma investor presentation spotlights Rare Disease shift, targets 2026 net revenue of $1.1 billion - BitgetBitget · Fri, 07 Aug 2026 11:36:24 GMTANI Pharma Q2 FY26 GAAP net income climbs 203.5% to $24.7 million; net revenues rise 25.9% to $266 million - BitgetBitget · Fri, 07 Aug 2026 11:22:43 GMTANI Pharmaceuticals Reports Second-Quarter 2026 Results, Raises Cortrophin Gel Guidance and Reaffirms Full-Year Outlook - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 11:00:00 GMT